VEGFA and age-related macular degeneration: Ranibizumab, Bevacizumab, Neovascular Age-related Macular Degeneration, Visual Acuity, Monthly Treatment, As-needed Treatment, Clinical Trial, Systemic Adverse Events, Vascular Endothelial Growth Factor, Treatment Regimen, Drug Comparison, Fluid Resolution, Arteriothrombotic Events, Serious Adverse Events